Related Experiment Video
Updated: May 5, 2026

Trans-Tympanic Drug Delivery for the Treatment of Ototoxicity
Published on: March 16, 2018
Challenges in interpreting the evidence for genetic predictors of ototoxicity
M J Ratain1, N J Cox, T O Henderson
1Department of Medicine, Comprehensive Cancer Center and Center for Personalized Therapeutics, The University of Chicago, Chicago, Illinois, USA.
Abstract:
There has been recent controversy regarding predictors of cisplatin-induced ototoxicity in children, as highlighted in a previous issue of this journal. We have reviewed the two articles that purport to show an association between TPMT and COMT variants and ototoxicity, as well as the related patent applications dating back to 2006. We summarize statistical issues not fully addressed by the authors that appear to have confounded the results of their studies.
Related Concept Videos
Drug Toxicity: Risk factors
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Principles of Pharmacogenetics: Types of Genetic Variants
Drug toxicity: Idiosyncratic Reactions
Pharmacogenetics and Pharmacogenomics: Overview
Gene-Environment Interactions

